<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05012527</url>
  </required_header>
  <id_info>
    <org_study_id>2021s01</org_study_id>
    <nct_id>NCT05012527</nct_id>
  </id_info>
  <brief_title>Retrospective Review of Gastrointestinal System Endoscopy Procedures</brief_title>
  <acronym>RRGIE</acronym>
  <official_title>Retrospective Review of Gastrointestinal System Endoscopy Procedures</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Istanbul Sultanbeyli State Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Istanbul Sultanbeyli State Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is retrospectively evaluating all features of endoscopic and&#xD;
      pathological diagnoses of cases who underwent upper and lower gastrointestinal endoscopy.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Gastrointestinal system endoscopy has an important place in the diagnosis and treatment of&#xD;
      many diseases related to this system and provides an alternative to current surgical methods&#xD;
      with its ever-expanding field of application. Upper and lower gastrointestinal endoscopy&#xD;
      procedures are performed with many indications, such as new complaints in the&#xD;
      gastrointestinal tract at the age of 50 and over, family history of gastrointestinal&#xD;
      malignancy. In addition, the importance of endoscopy is gradually increasing as tissue and&#xD;
      cell samples can be taken for histopathological studies and endoscopic treatment of some&#xD;
      diseases.&#xD;
&#xD;
      The aim of the study is to review patients' indications, distribution by age and gender,&#xD;
      frequency of lesions diagnosed on endoscopy, prevalence, size, histology and location of&#xD;
      polyps detected and excised, results of endoscopic and pathological diagnoses.&#xD;
&#xD;
      The study population consists of the patients who were examined at the Istanbul Sultanbeyli&#xD;
      State Hospital Endoscopy Unit between 01.01.2016 and 01.01.2021.&#xD;
&#xD;
      The patients' data will be scanned retrospectively by accessing their files from the computer&#xD;
      database.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 11, 2021</start_date>
  <completion_date type="Actual">October 1, 2021</completion_date>
  <primary_completion_date type="Actual">October 1, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Age</measure>
    <time_frame>During 3 months (retrospective endoscopy data review)</time_frame>
    <description>Age distribution of patients in endoscopic procedures and histopathological examinations</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Gender</measure>
    <time_frame>During 3 months (retrospective endoscopy data review)</time_frame>
    <description>Sex distribution of patients in endoscopic procedures and histopathological examinations</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Type of endoscopy</measure>
    <time_frame>During 3 months (retrospective endoscopy data review)</time_frame>
    <description>Number of each endoscopy, Type (esophagogastroduodenoscopy, colonoscopy, rectosigmoidoscopy)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Indications</measure>
    <time_frame>During 3 months (retrospective endoscopy data review)</time_frame>
    <description>Number of endoscopic indications, Type (Abnormal imaging, GI bleeding, Anemia, Screening and surveillance, Diarrhea, Constipation, Abdominal pain, Weight loss, Dyspepsia, Heartburn, Dysphagia, Odynophagia, Upper belly pain or chest pain that is not heart-related, Intractable vomiting, Bleeding in the upper, Persistent gastroesophageal reflux symptoms, Occult gastrointestinal bleeding, Other)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Procedure-related complications rates</measure>
    <time_frame>During 3 months (retrospective endoscopy data review)</time_frame>
    <description>The patients with complications / the total patients&#xD;
Number of adverse events; early or late (within 1 month), related to the endoscopic procedure, Type (cardiopulmonary complication, gastrointestinal bleeding, perforation, mortality)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Prevalence of benign/malign gastrointestinal disease in the endoscopy</measure>
    <time_frame>During 3 months (retrospective endoscopy data review)</time_frame>
    <description>The patients with benign gastrointestinal disease / the total patients&#xD;
The patients with malign gastrointestinal disease / the total patients</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Polyp/tumor detection rate of screening endoscopy</measure>
    <time_frame>During 3 months (retrospective endoscopy data review)</time_frame>
    <description>The patients with polyp / the total number of screening endoscopy patients&#xD;
The patients with tumor / the total number of screening endoscopy patients</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Polyp/tumor detection rate of symptomatic patients' endoscopy</measure>
    <time_frame>During 3 months (retrospective endoscopy data review)</time_frame>
    <description>The patients with polyp / the total number of symptomatic patients endoscopy&#xD;
The patients with tumor / the total number of symptomatic patients endoscopy</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Polyps localization and frequency</measure>
    <time_frame>During 3 months (retrospective endoscopy data review)</time_frame>
    <description>The patients with polyp / the total patients&#xD;
Number of polyp localizations, Type (Rectum, Sigmoid colon, Descending colon, Splenic flexure, Transverse colon, Hepatic flexure, Ascending colon, Caecum, Multiple localization)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Non-neoplastic biopsy results</measure>
    <time_frame>During 3 months (retrospective endoscopy data review)</time_frame>
    <description>The patients with non-neoplastic biopsy results / the total patients</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Prevalence of gastric/bowel diseases in histopathology</measure>
    <time_frame>During 3 months (retrospective endoscopy data review)</time_frame>
    <description>The patients with gastric disease / the total patients&#xD;
The patients with bowel disease / the total patients</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Prevalence of advanced neoplasia</measure>
    <time_frame>During 3 months (retrospective endoscopy data review)</time_frame>
    <description>The patients with advanced neoplasia / the total patients</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Prevalence of gastric/colorectal cancer</measure>
    <time_frame>During 3 months (retrospective endoscopy data review)</time_frame>
    <description>The patients with gastric cancer / the total patients&#xD;
The patients with colorectal cancer / the total patients</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Completeness rate of the procedures</measure>
    <time_frame>During 3 months (retrospective endoscopy data review)</time_frame>
    <description>The number of completed procedures / total number of procedures</description>
  </primary_outcome>
  <enrollment type="Actual">15448</enrollment>
  <condition>Endoscopy</condition>
  <condition>Colonoscopy</condition>
  <condition>Gastroscopy</condition>
  <condition>Colonic Polyps</condition>
  <condition>Endoscopy, Digestive System</condition>
  <condition>Gastrointestinal Neoplasms</condition>
  <condition>Biopsy</condition>
  <eligibility>
    <study_pop>
      <textblock>
        The study population consists of the patients who were examined at the Istanbul Sultanbeyli&#xD;
        State Hospital Endoscopy Unit between 01.01.2016 and 01.01.2021.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adult patients (over 18 years old)&#xD;
&#xD;
          -  Patients who have undergone the procedure in our endoscopy unit&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Under 18 years old&#xD;
&#xD;
          -  Patients whose information cannot be accessed in the system records.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Muhammer Ergen√ß, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Istanbul Sultanbeyli State Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Istanbul Sultanbeyli State Hospital</name>
      <address>
        <city>Istanbul</city>
        <zip>34935</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>July 15, 2021</study_first_submitted>
  <study_first_submitted_qc>August 12, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 19, 2021</study_first_posted>
  <last_update_submitted>October 2, 2021</last_update_submitted>
  <last_update_submitted_qc>October 2, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Istanbul Sultanbeyli State Hospital</investigator_affiliation>
    <investigator_full_name>Muhammer Ergen√ß, MD</investigator_full_name>
    <investigator_title>General Surgeon</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Gastrointestinal Neoplasms</mesh_term>
    <mesh_term>Digestive System Neoplasms</mesh_term>
    <mesh_term>Colonic Polyps</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

